KRAS WT Peptide (TFA)

KRAS WT Peptide TFA is the trifluoroacetate salt of KRAS WT Peptide. KRAS WT Peptide is the normal sequence peptide of the Kirsten rat sarcoma virus (KRAS) gene without oncogenic mutations. KRAS WT Peptide can be used for the study of evaluating the specificity and safety of KRAS-targeted immunotherapies[1].

Product Specifications

UNSPSC

12352209

Target

Others

Related Pathways

Others

Field of Research

Cancer

Purity

98.61

Smiles

O=C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C)C(NCC(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(C)C)N.OC(C(F)(F)F)=O.[x]

Molecular Formula

C37H67N11O11.xC2HF3O2

Molecular Weight

841.99 (free base)

References & Citations

[1]Zheng W, et al. Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncol Res. 2024 Nov 13;32 (12) :1837-1850.